This post uses hypothetical scenarios for illustrative purposes only. It does not describe any actual client, transaction, or representation, and is not legal advice.
A typical Florida optometry deal starts the same way as any other practice sale. Imagine a two-location practice — exam lanes in the back, an optical dispensary up front doing a healthy frames-and-lenses business — and an aggregator with private equity behind it that has already bought a dozen practices along the I-4 corridor. The letter of intent shows up with a respectable multiple, a rollover component, and a structure chart. And the first legal question is not price, escrow, or the non-compete. It’s whether the buyer can lawfully own what it thinks it’s buying — because in Florida, for the exam lanes, the answer is usually no.
Section 463.014 draws a line through the middle of the business
Florida’s optometry practice act, in section 463.014, prohibits the corporate practice of optometry from both directions at once. Subsection (1)(a) tells the entity: no corporation, lay body, organization, or individual other than a licensed practitioner may practice optometry by hiring optometrists — on salary, commission, or any other inducement. Subsection (1)(b) tells the doctor the same thing in mirror image: no licensed practitioner may practice optometry with any corporation, organization, group, or lay individual. The Board of Optometry has its own rule to match, and the two-sided design matters — a structure that flunks the statute doesn’t just expose the buyer, it puts the selling optometrist’s license on the line. Both parties have skin in the compliance question, which is why the structure chart gets negotiated as hard as the price.
The statute leaves two doors deliberately open. Licensed practitioners can employ and partner with other licensed practitioners — and, notably, can associate with multidisciplinary groups of licensed health care professionals whose primary object is diagnosis and treatment. And subsection (2) allows a corporation to employ optometrists to serve its own bona fide employees — an exception for the in-house clinic, useless for an aggregator whose customers are the public.
The dispensary is a different business under a different rule
Now look at the front of the store. Selling frames and filling lens prescriptions is retail, seasoned with Florida’s opticianry rules in chapter 484 — it is not the practice of optometry, and no statute stops a lay entity from owning it. Subsection (1)(c) even forecloses the Board from prohibiting optometrists from practicing in or on the premises of a commercial establishment. That’s the provision that makes the familiar retail model work: lay company owns the optical operation; independent optometrist practices in an adjacent space; patients walk from the exam lane to the frame wall. One storefront, two businesses, two ownership rules.
For deal lawyers, that means every Florida optometry acquisition is secretly an asset-separation exercise. The optical inventory, retail fixtures, dispensary staff, e-commerce accounts, and the lease can sit in the buyer’s entity. The professional side — patient records, the clinical staff relationships, the exam equipment if structured that way, and above all the practice of optometry itself — has to sit with a licensed practitioner. The purchase agreement is really two acquisitions wearing one cover page, and the allocation choices echo everywhere: purchase price allocation, sales tax on the tangible assets, payor credentialing, and which entity signs which employment agreement.
The MSO structure is how lay capital participates lawfully
So how does an aggregator buy the practice side at all? The same way lay capital participates in Florida dentistry and medicine: it doesn’t own the practice — it owns everything around the practice. A professional entity owned by a Florida-licensed optometrist owns the practice and employs or contracts the doctors. The buyer’s management services organization owns the non-clinical assets, holds the lease, employs the front-office staff, and provides administration, marketing, billing support, and capital under a long-term management services agreement, for a fee. The architecture will be familiar to anyone who has read my posts on Florida dental DSO deals and physician practice MSO structures — optometry is the third verse of the same song, with its own statute supplying the melody.
Three drafting points carry most of the risk. First, the management fee: it should be defensible as fair market value for the services actually provided — flat or cost-plus, documented, and reviewed — because a fee that floats as a percentage of clinical revenue starts to look like the corporation practicing optometry through the back door, the exact thing subsection (1)(a) prohibits. Second, clinical authority: the MSA should leave diagnosis, treatment, prescribing, referrals, staffing ratios in the exam lane, and patient-record control with the licensed practitioner, in writing and in practice — an MSO that sets exam-volume quotas is writing the regulator’s case file for it. Third, succession: because the buyer cannot own the professional entity, its continuity runs through a transfer-restriction agreement with the licensee — obligating the OD owner to transfer the equity to another licensed optometrist designated under the agreement’s terms on death, disability, license loss, or departure. That document is the buyer’s real security for the clinical side, and it gets drafted with the care other deals reserve for the purchase agreement itself.
Diligence has a chapter 463 flavor
Beyond the usual practice-sale checklist, Florida optometry adds its own items. Confirm each doctor’s licensure tier — a certified optometrist may administer and prescribe within the statute’s limits, but section 463.014 flatly prohibits treating systemic disease by drug and prohibits surgery, so a practice whose service mix drifts toward the edge of scope is buying a board complaint. Check the practice names against subsections (1)(d) and (1)(e): trade names must be tied to the licensee’s or professional association’s name in consumer communications, and quality-claiming names are prohibited outright — a rebrand to the aggregator’s national marque needs Florida-specific review, not a national style guide. Audit the dispensary’s chapter 484 posture, the vision-plan and Medicare credentialing (which will not transfer with a stock certificate the way people hope), and the records-custody plan, since patient records follow the professional entity, not the MSO.
What the closed deal looks like
Run the opening scene to its proper ending. The aggregator’s MSO buys the optical dispensary, the lease, the equipment, and the non-clinical operations in an asset purchase. A professional entity owned by a licensed optometrist — often the selling doctor, rolling over into the new structure — holds the practice, under a management agreement and a transfer-restriction agreement with the MSO. The selling doctor signs a sale-of-business non-compete sized to Florida’s standards, keeps the exam lanes, and gets liquidity for the enterprise value built over twenty years. Nobody owns anything section 463.014 says they can’t. The likely outcome, when the structure respects the statute, is a deal that closes quietly and a practice that runs the next morning — same lanes, same patients, new balance sheet. The deals that go sideways are almost never the ones where the parties asked the ownership question too carefully.
If you are buying or selling an optometry practice in Florida, feel free to reach out to my firm manager, Magda, at Magda@montague.law, or fill out our contact form. Mention you read this post.
